Divi’s Laboratories board to approve unaudited financial results

27 Oct 2020 Evaluate

Divi’s Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 07/11/2020, to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended 30 September, 2020. As intimated earlier, the Trading Window for dealing in securities of the Company has been closed from 01 October, 2020 till 48 hours after the declaration of financial results as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Divis Lab Share Price

3985.50 144.75 (3.77%)
26-Apr-2024 13:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1506.05
Dr. Reddys Lab 6278.95
Cipla 1410.60
Zydus Lifesciences 946.95
Lupin 1618.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.